Compass Therapeutics (NASDAQ:CMPX) Receives Outperform Rating from Wedbush

Wedbush reiterated their outperform rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report published on Tuesday,RTT News reports. They currently have a $8.00 price target on the stock. Other equities research analysts have also recently issued research reports about the stock. Jefferies Financial Group boosted their price target on shares of […]